Stock listing
KRX:456070 ENCell Co., Ltd. (이엔셀) 주가
Follow ENCell Co., Ltd. into a list and get an email when it puts out news.
Share price · KRX:456070
₩3,760.00 KRW -240.00 (-6.0%)
Close on Nov 20, 2026
- Day range
- ₩3,715.00 – ₩4,050.00 KRWNov 20, 2026
- Volume
- 44,705 sharesNov 20, 2026
- Market cap
- ₩41.37B KRWAt the close on Nov 20, 2026 · price × 11.00M shares outstanding
- 52-week range
- ₩3,715.00 – ₩20,950.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩795.1M KRWMedian day 38,934 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:456070 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩3,760.00 | -240.00 | -6.0% | ₩3,935.00 | ₩4,050.00 | ₩3,715.00 | 44,705 | |
| ₩4,000.00 | -160.00 | -3.8% | ₩4,100.00 | ₩4,270.00 | ₩3,960.00 | 52,168 | |
| ₩4,160.00 | -145.00 | -3.4% | ₩4,200.00 | ₩4,390.00 | ₩4,140.00 | 13,461 | |
| ₩4,305.00 | -30.00 | -0.7% | ₩4,335.00 | ₩4,365.00 | ₩4,225.00 | 12,149 | |
| ₩4,335.00 | -15.00 | -0.3% | ₩4,350.00 | ₩4,500.00 | ₩4,165.00 | 19,005 | |
| ₩4,350.00 | -195.00 | -4.3% | ₩4,490.00 | ₩4,590.00 | ₩4,350.00 | 21,121 | |
| ₩4,545.00 | +145.00 | +3.3% | ₩4,320.00 | ₩4,565.00 | ₩4,320.00 | 28,641 | |
| ₩4,400.00 | +200.00 | +4.8% | ₩4,265.00 | ₩4,535.00 | ₩4,235.00 | 104,955 | |
| ₩4,200.00 | +35.00 | +0.8% | ₩4,170.00 | ₩4,320.00 | ₩4,120.00 | 51,056 | |
| ₩4,165.00 | -175.00 | -4.0% | ₩4,190.00 | ₩4,320.00 | ₩4,020.00 | 39,519 | |
| ₩4,340.00 | -80.00 | -1.8% | ₩4,500.00 | ₩5,390.00 | ₩4,300.00 | 634,248 | |
| ₩4,420.00 | 0.00 | 0.0% | ₩4,420.00 | ₩4,650.00 | ₩4,190.00 | 38,348 | |
| ₩4,420.00 | -200.00 | -4.3% | ₩4,610.00 | ₩4,620.00 | ₩4,410.00 | 29,332 | |
| ₩4,620.00 | -55.00 | -1.2% | ₩4,615.00 | ₩4,715.00 | ₩4,540.00 | 56,790 | |
| ₩4,675.00 | -185.00 | -3.8% | ₩4,755.00 | ₩4,860.00 | ₩4,610.00 | 39,698 | |
| ₩4,860.00 | -170.00 | -3.4% | ₩4,925.00 | ₩5,030.00 | ₩4,620.00 | 83,674 | |
| ₩5,030.00 | +440.00 | +9.6% | ₩4,635.00 | ₩5,950.00 | ₩4,635.00 | 941,877 | |
| ₩4,590.00 | -75.00 | -1.6% | ₩4,650.00 | ₩4,820.00 | ₩4,585.00 | 31,934 | |
| ₩4,665.00 | -160.00 | -3.3% | ₩4,700.00 | ₩4,815.00 | ₩4,665.00 | 29,602 | |
| ₩4,825.00 | -75.00 | -1.5% | ₩4,800.00 | ₩4,905.00 | ₩4,655.00 | 28,833 | |
| ₩4,900.00 | -130.00 | -2.6% | ₩5,030.00 | ₩5,070.00 | ₩4,830.00 | 36,233 | |
| ₩5,030.00 | +30.00 | +0.6% | ₩5,040.00 | ₩5,280.00 | ₩5,010.00 | 25,885 | |
| ₩5,000.00 | -180.00 | -3.5% | ₩5,160.00 | ₩5,250.00 | ₩5,000.00 | 16,387 | |
| ₩5,180.00 | +120.00 | +2.4% | ₩4,860.00 | ₩5,250.00 | ₩4,860.00 | 26,086 | |
| ₩5,060.00 | +135.00 | +2.7% | ₩4,860.00 | ₩5,200.00 | ₩4,860.00 | 58,718 | |
| ₩4,925.00 | -265.00 | -5.1% | ₩5,110.00 | ₩5,260.00 | ₩4,800.00 | 69,534 | |
| ₩5,190.00 | -30.00 | -0.6% | ₩5,130.00 | ₩5,520.00 | ₩5,130.00 | 33,729 | |
| ₩5,220.00 | -200.00 | -3.7% | ₩5,150.00 | ₩5,380.00 | ₩5,050.00 | 54,290 | |
| ₩5,420.00 | -450.00 | -7.7% | ₩5,900.00 | ₩5,920.00 | ₩5,410.00 | 63,031 | |
| ₩5,870.00 | -130.00 | -2.2% | ₩5,950.00 | ₩5,980.00 | ₩5,770.00 | 59,026 | |
| ₩6,000.00 | -210.00 | -3.4% | ₩6,220.00 | ₩6,280.00 | ₩5,990.00 | 65,193 | |
| ₩6,210.00 | +210.00 | +3.5% | ₩6,070.00 | ₩6,240.00 | ₩5,930.00 | 90,304 | |
| ₩6,000.00 | -100.00 | -1.6% | ₩6,140.00 | ₩6,190.00 | ₩5,940.00 | 64,469 | |
| ₩6,100.00 | +270.00 | +4.6% | ₩5,860.00 | ₩6,160.00 | ₩5,730.00 | 116,526 | |
| ₩5,830.00 | +20.00 | +0.3% | ₩5,820.00 | ₩5,930.00 | ₩5,760.00 | 50,485 | |
| ₩5,810.00 | -370.00 | -6.0% | ₩6,100.00 | ₩6,100.00 | ₩5,760.00 | 96,690 | |
| ₩6,180.00 | +260.00 | +4.4% | ₩6,190.00 | ₩6,220.00 | ₩6,000.00 | 129,184 | |
| ₩5,920.00 | +20.00 | +0.3% | ₩5,880.00 | ₩6,050.00 | ₩5,800.00 | 113,985 | |
| ₩5,900.00 | -70.00 | -1.2% | ₩5,880.00 | ₩6,550.00 | ₩5,830.00 | 520,631 | |
| ₩5,970.00 | -650.00 | -9.8% | ₩6,830.00 | ₩6,890.00 | ₩5,950.00 | 667,108 | |
| ₩6,620.00 | +1,370.00 | +26.1% | ₩5,200.00 | ₩6,820.00 | ₩5,200.00 | 2,924,086 | |
| ₩5,250.00 | +80.00 | +1.5% | ₩5,150.00 | ₩5,250.00 | ₩5,100.00 | 15,268 | |
| ₩5,170.00 | -150.00 | -2.8% | ₩5,370.00 | ₩5,370.00 | ₩5,120.00 | 14,636 | |
| ₩5,320.00 | +170.00 | +3.3% | ₩5,150.00 | ₩5,400.00 | ₩5,100.00 | 20,728 | |
| ₩5,150.00 | -280.00 | -5.2% | ₩5,390.00 | ₩5,390.00 | ₩5,150.00 | 25,575 | |
| ₩5,430.00 | -140.00 | -2.5% | ₩5,580.00 | ₩5,590.00 | ₩5,390.00 | 16,800 | |
| ₩5,570.00 | +90.00 | +1.6% | ₩5,680.00 | ₩5,680.00 | ₩5,350.00 | 11,997 | |
| ₩5,480.00 | -110.00 | -2.0% | ₩5,530.00 | ₩5,890.00 | ₩5,450.00 | 21,696 | |
| ₩5,590.00 | +40.00 | +0.7% | ₩5,670.00 | ₩5,740.00 | ₩5,480.00 | 33,891 | |
| ₩5,550.00 | 0.00 | 0.0% | ₩5,550.00 | ₩5,640.00 | ₩5,480.00 | 16,071 | |
| ₩5,550.00 | +150.00 | +2.8% | ₩5,420.00 | ₩5,680.00 | ₩5,390.00 | 11,351 | |
| ₩5,400.00 | -210.00 | -3.7% | ₩5,610.00 | ₩5,780.00 | ₩5,400.00 | 26,697 | |
| ₩5,610.00 | -190.00 | -3.3% | ₩5,800.00 | ₩5,970.00 | ₩5,590.00 | 17,981 | |
| ₩5,800.00 | -120.00 | -2.0% | ₩5,920.00 | ₩5,920.00 | ₩5,740.00 | 20,092 | |
| ₩5,920.00 | -110.00 | -1.8% | ₩6,080.00 | ₩6,080.00 | ₩5,610.00 | 36,786 | |
| ₩6,030.00 | +60.00 | +1.0% | ₩5,930.00 | ₩6,110.00 | ₩5,850.00 | 22,751 | |
| ₩5,970.00 | -320.00 | -5.1% | ₩6,290.00 | ₩6,300.00 | ₩5,880.00 | 76,428 | |
| ₩6,290.00 | +420.00 | +7.2% | ₩5,900.00 | ₩6,880.00 | ₩5,900.00 | 368,913 | |
| ₩5,870.00 | -30.00 | -0.5% | ₩5,900.00 | ₩5,900.00 | ₩5,510.00 | 42,878 | |
| ₩5,900.00 | +200.00 | +3.5% | ₩5,740.00 | ₩6,040.00 | ₩5,740.00 | 28,189 | |
| ₩5,700.00 | -250.00 | -4.2% | ₩5,940.00 | ₩5,940.00 | ₩5,470.00 | 48,198 | |
| ₩5,950.00 | +20.00 | +0.3% | ₩6,150.00 | ₩6,530.00 | ₩5,950.00 | 49,851 |
- Ticker
- KRX:456070
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- KRX
- Currency
- KRW
What changed lately
Latest news release · Apr 20, 2026
Encell Wins 600 Million Won Order
Latest news
Encell Wins 600 Million Won Order
Apr 20, 2026
Closed ₩15,750 (-1.9%) on Apr 21, 2026
Encell Co Ltd - To Issue 2,800 Additional Shares
Dec 2, 2025
Closed ₩14,240 (+7.0%) on Dec 2, 2025
ENCell Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 2 in the last 12 months · 2 in all · newest Apr 20, 2026 · oldest 2025
Valuation
EV/sales 4.7× against a median of 1.8×: 8th lowest of 10 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩19.73B KRW
- P/E
- Loss
- EV/sales
- 4.7×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 1.5×
- Gross margin
- −67.4%
- Operating margin
- −435.8%
- Net margin
- −471.2%
- Debt to equity
- 0.3×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| ENCell Co., Ltd. · KRX:456070 | US$30.74M | US$14.66M | n/a | 4.7× | n/a | 1.5× | −471.2% | 0.3× | n/a |
| Trajan Group Holdings Ltd · ASX:TRJ | US$34.98M | US$65.05M | n/a | 0.6× | 7.6× | 0.5× | −0.4% | 0.6× | n/a |
| Novacyt SAS · EURONEXT:ALNOV | US$33.87M | US$35.59M | n/a | 0.8× | n/a | 1.4× | −102.4% | 0.6× | n/a |
| Rapid Micro Biosystems, Inc. · NASDAQ:RPID | US$33.56M | US$46.06M | n/a | 1.3× | n/a | 3.8× | −138.2% | 2.2× | 1.41 |
| Abnova Taiwan Corp. · TWSE:4133 | US$32.15M | US$20.35M | 23.6× | 1.9× | 13.4× | 0.8× | 13.0% | 0.0× | n/a |
| Precipio, Inc. · NASDAQ:PRPO | US$31.11M | US$27.88M | n/a | 1.0× | 119× | 2.1× | −4.1% | 0.0× | 1.00 |
| Aligned Genetics, Inc. · KRX:238120 | US$31.02M | US$28.31M | 9.0× | 2.4× | 11.8× | 1.1× | 28.7% | 0.3× | n/a |
| LabTurbo Biotech Corporation · TPEX:7725 | US$29.75M | US$4.98M | n/a | n/a | n/a | 0.8× | n/a | 0.0× | n/a |
| BioMark Diagnostics, Inc. · CSE:BUX | US$29.70M | US$29.15M | n/a | 1,504× | n/a | 74.6× | n/a | 0.0× | -0.11 |
| Bio Preventive Medicine Corp. · TPEX:6810 | US$29.41M | US$26.21M | n/a | 329× | n/a | 3.7× | n/a | 0.4× | n/a |
| Abingdon Health PLC · LSE:ABDX | US$28.13M | US$26.13M | n/a | 1.8× | n/a | 3.5× | −19.4% | 0.2× | n/a |
| Median of the others | US$31.06M | US$28.09M | 16.3× | 1.8× | 12.6× | 1.7× | −4.1% | 0.3× | 1.00 |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5.26B | 7.21B | 10.5B | 7.37B | 3.91B |
| Cost of revenue | 7.66B | 10.2B | 10.9B | 6.70B | 2.74B |
| Gross profit | -2.40B | -2.98B | -357.6M | 667.5M | 1.17B |
| Research and development | 7.73B | 6.64B | 6.07B | 5.73B | 2.10B |
| Selling, general and administrative | 2.15B | 5.63B | 4.77B | 3.92B | 368.7M |
| Operating income | -17.8B | -15.7B | -11.8B | -9.32B | -2.52B |
| Depreciation and amortization | 4.70B | 4.44B | 4.19B | 2.93B | 890.0M |
| EBITDA | -13.1B | -11.2B | -7.56B | -6.38B | -1.63B |
| Interest expense | 614.4M | 422.2M | 1.93B | 2.98B | 1.81B |
| Income before tax | -16.9B | -15.2B | -5.05B | -45.6B | -6.58B |
| Net income | -16.1B | -15.2B | -5.05B | -45.6B | -6.58B |
| Earnings per share, basic | -1,464.12 | -1,412.74 | -540.49 | -4,873.50 | -703.63 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | 38.5B | 30.6B | 12.7B | 5.78B | 5.90B |
| Short-term investments | 6.00B | 6.01B | 12.0B | ||
| Receivables | 1.22B | 2.58B | 2.01B | 939.1M | 237.7M |
| Inventory | 1.12B | 1.41B | 1.40B | 2.11B | 1.17B |
| Current assets | 43.7B | 35.5B | 22.9B | 31.6B | 20.6B |
| Property, plant and equipment | 18.2B | 20.0B | 22.3B | ||
| Total assets | 63.7B | 55.7B | 44.0B | 54.7B | 38.6B |
| Accounts payable | 204.7M | 65.5M | 194.6M | 67.8M | 141.8M |
| Current liabilities | 3.22B | 2.69B | 2.74B | 74.4B | 40.1B |
| Long-term debt | 9.00B | 550.0M | 850.0M | 1.15B | 1.45B |
| Total liabilities | 24.3B | 7.58B | 5.96B | 78.6B | 42.2B |
| Shareholders' equity | 39.4B | 48.2B | 38.0B | -23.8B | -3.63B |
| Shares outstanding | 11.0M | 10.8M | 9.35M | 9.35M | 9.35M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash from operations | -10.2B | -10.1B | -6.44B | -6.96B | -2.33B |
| Capital spending | -3.15B | -641.3M | -1.94B | -4.36B | -10.1B |
| Free cash flow | -13.3B | -10.7B | -8.38B | -11.3B | -12.4B |
| Cash from investing | 4.86B | 14.3B | -14.7B | ||
| Cash from financing | 23.1B | -939.9M | 21.6B | ||
| Share buybacks | 24.5B | 24.2B | |||
| Change in cash | 7.93B | 17.9B | 6.91B | -117.8M | -1.30B |
Cap table
Built by 6ix from ENCell Co., Ltd.’s releases
- Common shares
- 11,001,517
- Fully diluted
- 11,001,517
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 11,001,517 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 11,001,517 |
Log in to ask 6ix AI your own questions about ENCell Co., Ltd.